西亚试剂：Mutations driving CLL and their evolution in progression an

发布时间：2025-05-12

Which genetic alterations drive tumorigenesis and how they evolve over the course of disease and therapy are central questions in cancer biology. Here we identify 44 recurrently mutated genes and 11 recurrent somatic copy number variations through whole-exome sequencing of 538 chronic lymphocytic leukaemia (CLL) and matched germline samples, 278 of which were collected in a prospective clinical trial. These include previously unrecognized putative cancer drivers (RPS15, IKZF3), and collectively identify RNA processing and export, MYC activity, and MAPK signalling as central pathways involved in CLL. Clonality analysis of this large data set further enabled reconstruction of temporal relationships between driver events. Direct comparison between matched pre-treatment and relapse samples from 59 patients demonstrated highly frequent clonal evolution. Thus, large sequencing data sets of clinically informative samples enable the discovery of novel genes associated with cancer, the network of relationships between the driver events, and their impact on disease relapse and clinical outcome.

以上资料由西亚试剂：http://www.xiyashiji.com/ 提供

上一篇：西亚试剂:修复土壤污染，要过几道坎
下一篇：西亚试剂： [AD340X300]大千世界，色彩缤纷，人的大脑如何感知这一切？美国科学家在实验中发现了其中的机理。 英国《自然